GREAT GO analysis of WDR5 and MYCN overlapped ChIP-seq peaks with >2.5-fold decrease of WDR5 signal intensity after the silencing of <i>WDR5</i>. by Zhihui Liu (95891)

Induction of duodenal and hepatic Cyps in VD₃ deficient mice after DEX treatment. by Kavya Annu (11587215)

Subjects:

Despite impacting modeled aggregate primary PM_2.5 emissions changes as a result of the current clean vehicle rebate project scenario, different temporal charging distrib... by Jaye Mejía-Duwan (15401425)

Dasatinib oral gavage PK raw data. by Kavya Annu (11587215)

Subjects:

Proportion of VD₃ sufficient vs. deficient mice surviving from BCR-ABL ALL when treated with dexamethasone. by Kavya Annu (11587215)

Subjects:

DEX oral gavage PK raw data. by Kavya Annu (11587215)

Subjects:

Discontinuous DEX PK raw data from repeated study. by Kavya Annu (11587215)

Subjects:

Cartoon depicting dexamethasone and dasatinib metabolism and efflux transport in intestine and liver. by Kavya Annu (11587215)

Subjects:

Raw data from survival study in VD₃ sufficient vs. deficient male mice from BCR-ABL ALL when treated with dexamethasone. by Kavya Annu (11587215)

Subjects:

Gene expression (qPCR) data from VD3 sufficient and deficient hCYP3A4 12-week-old mice liver and kidney. by Kavya Annu (11587215)

Subjects:

Gene expression (qPCR) data from VD3 sufficient and deficient hCYP3A4 12-week-old mice duodenum. by Kavya Annu (11587215)

Subjects:

Kaplan-Meier curves for the effect of VD₃ sufficiency vs. deficiency on survival of mice from BCR-ABL Arf-/- leukemia. by Kavya Annu (11587215)

Subjects:

Cyp and transporter gene expression in liver and kidney of 12-week-old hCYP3A4 mice. by Kavya Annu (11587215)

Subjects:

Differences in plasma and gut dexamethasone concentrations following the oral discontinuous DEX regimen leads to tissue specific activation of GCR and PXR. by Kavya Annu (11587215)

Subjects:

Cyp and transporter gene expression in duodenum of VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

Subjects:

Dexamethasone plasma pharmacokinetics in male and female VD₃ sufficient and deficient mice, aged 14 weeks, after a single oral gavage of 2 mg/kg dexamethasone phosphate. by Kavya Annu (11587215)

Subjects:

Dasatinib plasma pharmacokinetics in male and female VD₃ sufficient and deficient mice after a single oral gavage of 10 mg/kg dasatinib. by Kavya Annu (11587215)

Subjects:

LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

The decrease of <i>CLB1</i> expression in the <i>puf5</i>Δ mutant contributes to the growth defect of the <i>puf5</i>Δ <i>clb2</i>Δ double mutant. by Megumi Sato (4116994)

Percentage of Saudi subjects carrying actionable variants in zero to five pharmacogenomics genes. by Ewa Goljan (3463487)

Subjects: